Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Asset Utilization Ratio (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Asset Utilization Ratio for 14 consecutive years, with 0.51 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 9.98% to 0.51 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.51, a 9.98% decrease, with the full-year FY2025 number at 0.55, up 7.0% from a year prior.
  • Asset Utilization Ratio was 0.51 for Q4 2025 at Aytu Biopharma, down from 0.51 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.76 in Q2 2023 to a low of 0.25 in Q3 2021.
  • A 5-year average of 0.58 and a median of 0.57 in 2024 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 190.3% in 2022, then fell 26.04% in 2024.
  • Aytu Biopharma's Asset Utilization Ratio stood at 0.3 in 2021, then soared by 138.8% to 0.72 in 2022, then decreased by 5.92% to 0.68 in 2023, then decreased by 17.34% to 0.56 in 2024, then decreased by 9.98% to 0.51 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Asset Utilization Ratio are 0.51 (Q4 2025), 0.51 (Q3 2025), and 0.53 (Q2 2025).